The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, ...

IDSA recommends shorter antibiotic courses for adults with cUTIs who show clinical improvement on effective therapy.

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...

A stewardship initiative improved guideline-adherent UTI management and reduced unnecessary treatment for AUPs.

Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...

Escherichia coli (E. coli) is a bacteria that commonly causes UTIs. When an infection occurs, doctors prescribe antibiotics to help treat it. E. coli is a type of bacteria that lives in the gut ...

Scientists are developing what they hope to be an alternative treatment for chronic urinary tract infections (UTI), which could help millions of patients suffering from the agonising condition.

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...